SKVI Financials Monday, July 14, 2014 11:02:30 PM
Skinvisible, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 67 270 180 229
Cost of Revenue 2 5 2 19
Gross Profit 65 266 179 210
Operating Expenses
Research and Development - - - -
Sales, General and Admin. 787 1,538 1,350 968
Non-Recurring Items - - - -
Other 37 52 56 42
Operating Income (760) (1,324) (1,228) (800)
Income From Continuing Operations
Add'l Income/Expense Items 4 45 (5) -
Earnings Before Interest and Tax (759) (1,293) (1,228) (800)
Interest Expense 588 174 127 273
Earnings Before Tax (1,347) (1,467) (1,355) (1,073)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (1,343) (1,452) (1,360) (1,073)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (1,343) (1,452) (1,360) (1,073)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (1,343) (1,452) (1,360) (1,073)
Skinvisible, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 67 270 180 229
Cost of Revenue 2 5 2 19
Gross Profit 65 266 179 210
Operating Expenses
Research and Development - - - -
Sales, General and Admin. 787 1,538 1,350 968
Non-Recurring Items - - - -
Other 37 52 56 42
Operating Income (760) (1,324) (1,228) (800)
Income From Continuing Operations
Add'l Income/Expense Items 4 45 (5) -
Earnings Before Interest and Tax (759) (1,293) (1,228) (800)
Interest Expense 588 174 127 273
Earnings Before Tax (1,347) (1,467) (1,355) (1,073)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (1,343) (1,452) (1,360) (1,073)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (1,343) (1,452) (1,360) (1,073)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (1,343) (1,452) (1,360) (1,073)